(NASDAQ: HAS), a leading games, IP and toy company, today celebrated the opening of its new 600,000-square-foot distribution ...
Flexiv Secures Capital from Leading Evergreen Investor to Scale Global Deployment of Adaptive Robots
Flexiv, a global leader in general-purpose robotics, is pleased to announce that it has secured a new strategic investment.
Overall satisfaction with original equipment tires among battery electric vehicles (BEVs), internal combustion engine (ICE) vehicles and plug-in hybrid electric vehicles (PHEVs) continues to converge, ...
NuScale Power Corporation (NYSE: SMR) (NuScale), the industry-leading provider of proprietary and innovative advanced small modular reactor (SMR) nuclear technology, and Ebara Elliott Energy (EEE), a ...
Bristol Myers Squibb (NYSE: BMY) will announce results for the first quarter of 2026 on Thursday, April 30, 2026. Company executives will review financial results with the investment community during ...
Adastra, a global leader in AI and data-driven transformation, today announced it has achieved the AWS Consumer Goods Competency from Amazon Web Services (AWS). This designation recognizes Adastra’s ...
NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in ...
Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, announced ...
Modiv Industrial, Inc. (“Modiv” or the “Company”) (NYSE:MDV), the only public REIT exclusively focused on acquiring industrial manufacturing real estate properties, today announced that it will report ...
BIOQuébec, the association representing the life sciences and health technologies (LSHT) industry, notes that the government is exercising caution by maintaining its direction for these strategic ...
(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...
Pursuing reimbursement coverage from one or more regional insurance providers in the United States as an important step toward broader payer adoption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results